Journal
ONCOGENE
Volume 27, Issue 48, Pages 6228-6244Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2008.300
Keywords
NF-kappa B; liver disease; hepatitis; hepatocellular carcinoma; apoptosis
Funding
- Jiangsu Province's Outstanding Medical Academic Leader program [RC2007057]
- Natural Science Foundation of China [30672367]
- Ministry of Health, China [Wkj2006-2-021]
- Jiangsu Province 'six adults just' high peak [06-B-032]
- National Institutes of Health (NIH)
- American Association for Cancer Research (AACR)
Ask authors/readers for more resources
The NF-kappa B signaling pathway has particular relevance to several liver diseases including hepatitis (liver infection by Helicobacter, viral hepatitis induced by HBV and HCV), liver fibrosis and cirrhosis and hepatocellular carcinoma. Furthermore, the NF-kappa B signaling pathway is a potential target for development of hepatoprotective agents. Several types of drugs including: selective estrogen receptor modulators (SERMs), antioxidants, proteasome inhibitors, IKK inhibitors and nucleic acid-based decoys have been shown to interfere with NF-kappa B activity at different levels and may be useful for the treatment of liver diseases. However, NF-kappa B also plays an important hepatoprotective function that needs to be taken into consideration during development of new therapeutic regimens.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available